Near Infrared Analysis of Tablets Containing Two Active Ingredients

FOSS NIRSystems, Inc. is pleased to announce that a new NIR article has been published on the subject: Near Infrared Analysis of Tablets Containing Two Active Ingredients.

This study evaluates Near-Infrared (NIR) analysis of tablets nominally containing 4 mg of chlorpheniramine maleate (CPM) and 10 mg of phenylephrine hydrochloride (PE-HCl) per dose. The data showed promising results that could relieve laboratory workload and bring analysis closer to real time for process monitoring. Ten tablets could be analyzed in less than 3 min. The NIR assay for the determination of tablets' CU is a fast and accurate means of monitoring tablets that could be used for production and is consistent with FDA's PAT initiative.

For more information about this article, please contact Applications Scientist Robert Mattes at

rmattes@foss-nirsystems.com